expert reaction to new WHO guideline for GLP-1 medications
Scientists comment on new WHO guidelines for GLP-1 medications for the treatment of obesity, published by JAMA. Dr Marie Spreckley, … read more
Scientists comment on new WHO guidelines for GLP-1 medications for the treatment of obesity, published by JAMA. Dr Marie Spreckley, … read more
Scientists respond to article published in Nature Medicine exploring the link between weight-loss drugs and food cravings. Dr Simon Cork, Senior … read more
A study published in the Lancet looks at semaglutide and cardiovascular health regardless of weight loss. Dr Sonya Babu-Narayan, Clinical Director, … read more
Two studies published in The Lancet Diabetes & Endocrinology looks at the effect of higher doses of semaglutide on weight loss … read more
An unpublished conference abstract presented at the European Association for the Study of Diabetes (EASD) in Vienna looks at the … read more
An observational study published in JAMA Oncology looks at GLP-1 receptor agonists and cancer risk in adults with obesity. Prof Paul … read more
Scientists comment on oral GLP-1 (Orforglipron) and weight loss from a phase 3 clinical trial. Dr Simon Cork, Senior … read more
A study published in The BMJ compares the evidence around intermittent fasting and calorie restriction for weight loss. Prof Maik Pietzner, … read more
Scientists comment on the MHRA advice on contraceptives for women taking weight loss drugs. Dr Caroline Ovadia, Senior Clinical … read more
A systematic review published in JAMA Psychiatry looks at weight loss drugs (GLP-1 receptor agonists) and mental health. Prof Stella Chan, Charlie … read more
A conference poster presented at the European Congress on Obesity (ECO) in Malaga and published in eClinicalMedicine looks at obesity … read more
Scientists comment on phase 3 trial results of Lilly’s oral GLP-1 (Orforflipron). Prof Naveed Sattar, Professor of Cardiometabolic Medicine/Honorary … read more
A study published in the Annals of Internal Medicine looks at the effect of 4:3 intermittent fasting on weight loss. Dr … read more
A study published in JAMA Psychiatry looks at the use of semaglutide in adults with alcohol use disorder. Prof Felicity Gavins, … read more
A study published in BMJ Nutrition, Prevention & Health looks at carbonated water and weight loss. Catherine Collins, Intensive care … read more
A study published in Nature Medicine looks at the health risks and benefits linked to GLP-1 receptor agonists. Prof Naveed Sattar, … read more
More than one billion people are estimated to be living with obesity globally. A new global Commission on obesity is … read more
A global commission published in the Lancet Diabetes and Endocrinology looks at the definition and diagnosis of clinical obesity. Prof Simon … read more
Scientists comment on final NICE draft guidance on the use of Tirzepatide (Mounjaro) for obesity. Helen Kirrane, Head of … read more
Scientists comment on the risks and benefits of tirzepatide (Mounjaro) after a UK death linked to the drug. Prof … read more